You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects
|
---|---|
Published in |
Breast Cancer Research, March 2014
|
DOI | 10.1186/bcr3632 |
Pubmed ID | |
Authors |
Shanshan Zhao, Rowan T Chlebowski, Garnet L Anderson, Lewis H Kuller, JoAnn E Manson, Margery Gass, Ruth Patterson, Thomas E Rohan, Dorothy S Lane, Shirley AA Beresford, Sayeh Lavasani, Jacques E Rossouw, Ross L Prentice |
Abstract |
Paradoxically, a breast cancer risk reduction with conjugated equine estrogens (CEE) and a risk elevation with CEE plus medroxyprogesterone acetate (CEE + MPA) were observed in the Women's Health Initiative (WHI) randomized controlled trials. The effects of hormone therapy on serum sex hormone levels, and on the association between baseline sex hormones and disease risk, may help explain these divergent breast cancer findings. |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 2 | 3% |
Unknown | 60 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 15 | 24% |
Student > Ph. D. Student | 7 | 11% |
Researcher | 6 | 10% |
Other | 5 | 8% |
Student > Doctoral Student | 4 | 6% |
Other | 9 | 15% |
Unknown | 16 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 23 | 37% |
Biochemistry, Genetics and Molecular Biology | 8 | 13% |
Agricultural and Biological Sciences | 5 | 8% |
Nursing and Health Professions | 4 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 4 | 6% |
Unknown | 16 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2014.
All research outputs
#4,164,588
of 22,753,345 outputs
Outputs from Breast Cancer Research
#498
of 1,894 outputs
Outputs of similar age
#41,723
of 224,566 outputs
Outputs of similar age from Breast Cancer Research
#5
of 27 outputs
Altmetric has tracked 22,753,345 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,894 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,566 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.